Current Potential for Clinical Optimization of Social Cognition Assessment for Frontotemporal Dementia and Primary Psychiatric Disorders.

Differential diagnosis Frontotemporal dementia Primary psychiatric disorders Social cognition

Journal

Neuropsychology review
ISSN: 1573-6660
Titre abrégé: Neuropsychol Rev
Pays: United States
ID NLM: 9009029

Informations de publication

Date de publication:
06 2023
Historique:
received: 04 08 2021
accepted: 10 05 2022
medline: 1 5 2023
pubmed: 14 8 2022
entrez: 13 8 2022
Statut: ppublish

Résumé

Dodich and colleagues recently reviewed the evidence supporting clinical use of social cognition assessment in behavioral variant frontotemporal dementia (Dodich et al., 2021). Here, we comment on their methods and present an initiative to address some of the limitations that emerged from their study. In particular, we established the social cognition workgroup within the Neuropsychiatric International Consortium Frontotemporal dementia (scNIC-FTD), aiming to validate social cognition assessment for diagnostic purposes and tracking of change across clinical situations.

Identifiants

pubmed: 35962919
doi: 10.1007/s11065-022-09554-3
pii: 10.1007/s11065-022-09554-3
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

544-550

Subventions

Organisme : NIA NIH HHS
ID : RF1 AG029577
Pays : United States

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Boccardi, M., Gallo, V., Yasui, Y., Vineis, P., Padovani, A., Mosimann, U., Giannakopoulos, P., Gold, G., Dubois, B., Jack, C. R., Jr., Winblad, B., Frisoni, G. B., Albanese, E., Force, G. T., & for the Roadmap of Alzheimer’s, B. (2017). Apr). The biomarker-based diagnosis of Alzheimer’s disease. 2-lessons from oncology. Neurobiology of Aging, 52, 141–152. https://doi.org/10.1016/j.neurobiolaging.2017.01.021
doi: 10.1016/j.neurobiolaging.2017.01.021 pubmed: 28317645
Boccardi, M., Monsch, A. U., Ferrari, C., Altomare, D., Berres, M., Bos, I., Buchmann, A., Cerami, C., Didic, M., Festari, C., Nicolosi, V., Sacco, L., Aerts, L., Albanese, E., Annoni, J. M., Ballhausen, N., Chicherio, C., Demonet, J. F., Descloux, V., Diener, S., Ferreira, D., Georges, J., Gietl, A., Girtler, N., Kilimann, I., Kloppel, S., Kustyniuk, N., Mecocci, P., Mella, N., Pigliautile, M., Seeher, K., Shirk, S. D., Toraldo, A., Brioschi-Guevara, A., Chan, K. C. G., Crane, P. K., Dodich, A., Grazia, A., Kochan, N. A., de Oliveira, F. F., Nobili, F., Kukull, W., Peters, O., Ramakers, I., Sachdev, P. S., Teipel, S., Visser, P. J., Wagner, M., Weintraub, S., Westman, E., Froelich, L., Brodaty, H., Dubois, B., Cappa, S. F., Salmon, D., Winblad, B., Frisoni, G. B., Kliegel, M., & Consortium for the Harmonization of Neuropsychological Assessment for Neurocognitive, D. (2021, May 13). Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe. Alzheimers Dement. https://doi.org/10.1002/alz.12365
Caminiti, S. P., Ballarini, T., Sala, A., Cerami, C., Presotto, L., Santangelo, R., Fallanca, F., Vanoli, E. G., Gianolli, L., Iannaccone, S., Magnani, G., Perani, D., & Project, B. (2018). FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort. Neuroimage Clin, 18, 167–177. https://doi.org/10.1016/j.nicl.2018.01.019
doi: 10.1016/j.nicl.2018.01.019
Cerami, C., Dubois, B., Boccardi, M., Monsch, A. U., Demonet, J. F., Cappa, S. F., Force, G. T., & for the Roadmap of Alzheimer’s, B. (2017). Apr). Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer’s disease in the context of a structured 5-phase development framework. Neurobiology of Aging, 52, 153–166. https://doi.org/10.1016/j.neurobiolaging.2016.03.034
doi: 10.1016/j.neurobiolaging.2016.03.034 pubmed: 28317646
Chiu, I., Piguet, O., Diehl-Schmid, J., Riedl, L., Beck, J., Leyhe, T., Holsboer-Trachsler, E., Kressig, R. W., Berres, M., Monsch, A. U., & Sollberger, M. (2018, Jan/Feb). Facial Emotion Recognition Performance Differentiates Between Behavioral Variant Frontotemporal Dementia and Major Depressive Disorder. The Journal of Clinical Psychiatry, 79(1). https://doi.org/10.4088/JCP.16m11342
Cook, L., Souris, H., & Isaacs, J. (2020). The 2019 national memory service audit. NHS London Clinical Networks.
De Vocht, J., Blommaert, J., Devrome, M., Radwan, A., Van Weehaeghe, D., De Schaepdryver, M., Ceccarini, J., Rezaei, A., Schramm, G., van Aalst, J., Chio, A., Pagani, M., Stam, D., Van Esch, H., Lamaire, N., Verhaegen, M., Mertens, N., Poesen, K., van den Berg, L. H., van Es, M. A., Vandenberghe, R., Vandenbulcke, M., Van den Stock, J., Koole, M., Dupont, P., Van Laere, K., & Van Damme, P. (2020, Aug 1). Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion. JAMA Neurology, 77(8), 1008–1017. https://doi.org/10.1001/jamaneurol.2020.1087
Dodich, A., Crespi, C., Santi, G. C., Cappa, S. F., & Cerami, C. (2021, Jun). Evaluation of Discriminative Detection Abilities of Social Cognition Measures for the Diagnosis of the Behavioral Variant of Frontotemporal Dementia: a Systematic Review. Neuropsychology Review, 31(2), 251–266. https://doi.org/10.1007/s11065-020-09457-1
Dubois, B., Villain, N., Frisoni, G. B., Rabinovici, G. D., Sabbagh, M., Cappa, S., Bejanin, A., Bombois, S., Epelbaum, S., Teichmann, M., Habert, M. O., Nordberg, A., Blennow, K., Galasko, D., Stern, Y., Rowe, C. C., Salloway, S., Schneider, L. S., Cummings, J. L., & Feldman, H. H. (2021, Jun). Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. Lancet Neurology, 20(6), 484–496. https://doi.org/10.1016/S1474-4422(21)00066-1
Ducharme, S., Dols, A., Laforce, R., Devenney, E., Kumfor, F., Van den Stock, J., Dallaire-Theroux, C., Seelaar, H., Gossink, F., Vijverberg, E., Huey, E., Vandenbulcke, M., Masellis, M., Trieu, C., Onyike, C., Caramelli, P., de Souza, L. C., Santillo, A., Waldo, M. L., Landin-Romero, R., Piguet, O., Kelso, W., Eratne, D., Velakoulis, D., Ikeda, M., Perry, D., Pressman, P., Boeve, B., Vandenberghe, R., Mendez, M., Azuar, C., Levy, R., Le Ber, I., Baez, S., Lerner, A., Ellajosyula, R., Pasquier, F., Galimberti, D., Scarpini, E., van Swieten, J., Hornberger, M., Rosen, H., Hodges, J., Diehl-Schmid, J., & Pijnenburg, Y. (2020, Jun 1). Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. Brain, 143(6), 1632–1650. https://doi.org/10.1093/brain/awaa018
Faust, D. (1986). Research on juman judgement and its application to clinical practice. Professional Psychology: Research and Practice, 17(5), 420–430.
doi: 10.1037/0735-7028.17.5.420
Faust, D., & Nurcombe, B. (1989, May). Improving the accuracy of clinical judgment. Psychiatry, 52(2), 197–208. https://doi.org/10.1080/00332747.1989.11024443
Frisoni, G. B., Boccardi, M., Barkhof, F., Blennow, K., Cappa, S., Chiotis, K., Demonet, J. F., Garibotto, V., Giannakopoulos, P., Gietl, A., Hansson, O., Herholz, K., Jack, C. R., Jr., Nobili, F., Nordberg, A., Snyder, H. M., Ten Kate, M., Varrone, A., Albanese, E., Becker, S., Bossuyt, P., Carrillo, M. C., Cerami, C., Dubois, B., Gallo, V., Giacobini, E., Gold, G., Hurst, S., Lonneborg, A., Lovblad, K. O., Mattsson, N., Molinuevo, J. L., Monsch, A. U., Mosimann, U., Padovani, A., Picco, A., Porteri, C., Ratib, O., Saint-Aubert, L., Scerri, C., Scheltens, P., Schott, J. M., Sonni, I., Teipel, S., Vineis, P., Visser, P. J., Yasui, Y., & Winblad, B. (2017, Aug). Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. Lancet Neurol, 16(8), 661–676. https://doi.org/10.1016/S1474-4422(17)30159-X
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., Manes, F., Dronkers, N. F., Vandenberghe, R., Rascovsky, K., Patterson, K., Miller, B. L., Knopman, D. S., Hodges, J. R., Mesulam, M. M., & Grossman, M. (2011, Mar 15). Classification of primary progressive aphasia and its variants. Neurology, 76(11), 1006–1014. https://doi.org/10.1212/WNL.0b013e31821103e6
Gregory, C., Lough, S., Stone, V., Erzinclioglu, S., Martin, L., Baron-Cohen, S., & Hodges, J. R. (2002, Apr). Theory of mind in patients with frontal variant frontotemporal dementia and Alzheimer's disease: theoretical and practical implications. Brain, 125(Pt 4), 752–764. https://doi.org/10.1093/brain/awf079
Harris, J. M., Gall, C., Thompson, J. C., Richardson, A. M., Neary, D., du Plessis, D., Pal, P., Mann, D. M., Snowden, J. S., & Jones, M. (2013, May 14). Sensitivity and specificity of FTDC criteria for behavioral variant frontotemporal dementia. Neurology, 80(20), 1881–1887. https://doi.org/10.1212/WNL.0b013e318292a342
Harris, J. M., Thompson, J. C., Gall, C., Richardson, A. M., Neary, D., du Plessis, D., Pal, P., Mann, D. M., Snowden, J. S., & Jones, M. (2015, Feb). Do NIA-AA criteria distinguish Alzheimer's disease from frontotemporal dementia? Alzheimers Dement, 11(2), 207–215. https://doi.org/10.1016/j.jalz.2014.04.516
Hutchings, R., Hodges, J. R., Piguet, O., Kumfor, F., & Boutoleau-Bretonniere, C. (2015). Why Should I Care? Dimensions of Socio-Emotional Cognition in Younger-Onset Dementia. Journal of Alzheimer’s Disease, 48(1), 135–147. https://doi.org/10.3233/JAD-150245
doi: 10.3233/JAD-150245 pubmed: 26401935
Johnen, A., & Bertoux, M. (2019). Psychological and Cognitive Markers of Behavioral Variant Frontotemporal Dementia-A Clinical Neuropsychologist’s View on Diagnostic Criteria and Beyond. Frontiers in Neurology, 10, 594. https://doi.org/10.3389/fneur.2019.00594
doi: 10.3389/fneur.2019.00594 pubmed: 31231305 pmcid: 6568027
Krudop, W. A., Dols, A., Kerssens, C. J., Eikelenboom, P., Prins, N. D., Moller, C., Schouws, S., Rhebergen, D., van Exel, E., van der Flier, W. M., Sikkes, S., Scheltens, P., Stek, M. L., & Pijnenburg, Y. A. L. (2017). The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria. Journal of Alzheimer’s Disease, 60(3), 959–975. https://doi.org/10.3233/JAD-170608
doi: 10.3233/JAD-170608 pubmed: 28984605
Kumfor, F., Hazelton, J. L., De Winter, F.-L., Cleret de Langavant, L., & Van den Stock, J. (2017). Clinical Studies of Social Neuroscience: A Lesion Model Approach. In A. Ibáñez, L. Sedeño, & A. M. García (Eds.), Neuroscience and Social Science: The Missing Link (pp. 255–296). Springer. https://doi.org/10.1007/978-3-319-68421-5_12
Lansdall, C. J., Coyle-Gilchrist, I. T. S., Jones, P. S., Vazquez Rodriguez, P., Wilcox, A., Wehmann, E., Dick, K. M., Robbins, T. W., & Rowe, J. B. (2017, Jun 1). Apathy and impulsivity in frontotemporal lobar degeneration syndromes. Brain, 140(6), 1792–1807. https://doi.org/10.1093/brain/awx101
Lavenu, I., Pasquier, F., Lebert, F., Petit, H., & Van der Linden, M. (1999, Apr-Jun). Perception of emotion in frontotemporal dementia and Alzheimer disease. Alzheimer Disease Association Disorder, 13(2), 96–101. https://doi.org/10.1097/00002093-199904000-00007
Leroy, M., Bertoux, M., Skrobala, E., Mode, E., Adnet-Bonte, C., Le Ber, I., Bombois, S., Cassagnaud, P., Chen, Y., Deramecourt, V., Lebert, F., Mackowiak, M. A., Sillaire, A. R., Wathelet, M., Pasquier, F., Lebouvier, T., & Meotis, n. (2021, Jan 8). Characteristics and progression of patients with frontotemporal dementia in a regional memory clinic network. Alzheimers Research Therapy, 13(1), 19. https://doi.org/10.1186/s13195-020-00753-9
Mendez, M. F., & Shapira, J. S. (2011, Dec). Loss of emotional insight in behavioral variant frontotemporal dementia or "frontal anosodiaphoria". Consciousness and Cognition, 20(4), 1690–1696. https://doi.org/10.1016/j.concog.2011.09.005
Mercy, L., Hodges, J. R., Dawson, K., Barker, R. A., & Brayne, C. (2008, Nov 4). Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology, 71(19), 1496–1499. https://doi.org/10.1212/01.wnl.0000334277.16896.fa
Nobili, F., Arbizu, J., Bouwman, F., Drzezga, A., Agosta, F., Nestor, P., Walker, Z., Boccardi, M., & Disorders, E.-E. T. F. f. t. P. o. F.-P. f. D. N. (2018, Oct). European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain (18) F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. European Journal of Neurology, 25(10), 1201–1217. https://doi.org/10.1111/ene.13728
Rankin, K. P. (2021). Measuring Behavior and Social Cognition in FTLD. In B. Ghetti, E. Buratti, B. Boeve, & R. Rademakers (Eds.), Frontotemporal Dementias : Emerging Milestones of the 21st Century (pp. 51–65). Springer International Publishing. https://doi.org/10.1007/978-3-030-51140-1_4
Rankin, K. P., Santos-Modesitt, W., Kramer, J. H., Pavlic, D., Beckman, V., & Miller, B. L. (2008, Jan). Spontaneous social behaviors discriminate behavioral dementias from psychiatric disorders and other dementias. The Journal of Clinical Psychiatry, 69(1), 60–73. https://doi.org/10.4088/jcp.v69n0109
Rankin, K. P., Toller, G., Gavron, L., La Joie, R., Wu, T., Shany-Ur, T., Callahan, P., Krassner, M., Kramer, J. H., & Miller, B. L. (2021). Social Behavior Observer Checklist: Patterns of Spontaneous Behaviors Differentiate Patients With Neurodegenerative Disease From Healthy Older Adults. Frontiers in Neurology. https://doi.org/10.3389/fneur.2021.683162
doi: 10.3389/fneur.2021.683162 pubmed: 34557141 pmcid: 8452879
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G., Onyike, C. U., Hillis, A. E., Josephs, K. A., Boeve, B. F., Kertesz, A., Seeley, W. W., Rankin, K. P., Johnson, J. K., Gorno-Tempini, M. L., Rosen, H., Prioleau-Latham, C. E., Lee, A., Kipps, C. M., Lillo, P., Piguet, O., Rohrer, J. D., Rossor, M. N., Warren, J. D., Fox, N. C., Galasko, D., Salmon, D. P., Black, S. E., Mesulam, M., Weintraub, S., Dickerson, B. C., Diehl-Schmid, J., Pasquier, F., Deramecourt, V., Lebert, F., Pijnenburg, Y., Chow, T. W., Manes, F., Grafman, J., Cappa, S. F., Freedman, M., Grossman, M., & Miller, B. L. (2011, Sep). Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain, 134(Pt 9), 2456–2477. https://doi.org/10.1093/brain/awr179
Schaeverbeke, J. M., Gabel, S., Meersmans, K., Luckett, E. S., De Meyer, S., Adamczuk, K., Nelissen, N., Goovaerts, V., Radwan, A., Sunaert, S., Dupont, P., Van Laere, K., & Vandenberghe, R. (2021, Apr 7). Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults. Alzheimers Research Therapy, 13(1), 75. https://doi.org/10.1186/s13195-021-00798-4
Schulz, R., Cook, T. B., Beach, S. R., Lingler, J. H., Martire, L. M., Monin, J. K., & Czaja, S. J. (2013, Jan). Magnitude and causes of bias among family caregivers rating Alzheimer disease patients. American Journal of Geriatric Psychiatry, 21(1), 14–25. https://doi.org/10.1016/j.jagp.2012.10.002
Shinagawa, S., Catindig, J. A., Block, N. R., Miller, B. L., & Rankin, K. P. (2016). When a Little Knowledge Can Be Dangerous: False-Positive Diagnosis of Behavioral Variant Frontotemporal Dementia among Community Clinicians. Dementia and Geriatric Cognitive Disorders, 41(1–2), 99–108. https://doi.org/10.1159/000438454
doi: 10.1159/000438454 pubmed: 26741499
Tenny, S., & Hoffman, M. R. (2021). Prevalence. In StatPearls. https://www.ncbi.nlm.nih.gov/pubmed/28613617
Van den Stock, J. (2021, Dec 2). Social cognition assessment for mild neurocognitive disorders. Alzheimers Dement. https://doi.org/10.1002/alz.12475
Vijverberg, E. G., Dols, A., Krudop, W. A., Peters, A., Kerssens, C. J., van Berckel, B. N., Wattjes, M. P., Barkhof, F., Gossink, F., Prins, N. D., Stek, M. L., Scheltens, P., & Pijnenburg, Y. A. (2016). Diagnostic Accuracy of the Frontotemporal Dementia Consensus Criteria in the Late-Onset Frontal Lobe Syndrome. Dementia and Geriatric Cognitive Disorders, 41(3–4), 210–219. https://doi.org/10.1159/000444849
doi: 10.1159/000444849 pubmed: 27160162
Wedding, D., & Faust, D. (1989). Clinical judgment and decision making in neuropsychology. Archives of Clinical Neuropsychology, 4(3), 233–265. https://www.ncbi.nlm.nih.gov/pubmed/14589608
Weintraub, S., Besser, L., Dodge, H. H., Teylan, M., Ferris, S., Goldstein, F. C., Giordani, B., Kramer, J., Loewenstein, D., Marson, D., Mungas, D., Salmon, D., Welsh-Bohmer, K., Zhou, X. H., Shirk, S. D., Atri, A., Kukull, W. A., Phelps, C., & Morris, J. C. (2018, Jan-Mar). Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Disease Association Disorder, 32(1), 10–17. https://doi.org/10.1097/WAD.0000000000000223

Auteurs

Jan Van den Stock (J)

Leuven Brain Institute, Department of Neurosciences, Research Group Psychiatry, Neuropsychiatry, KU Leuven, Leuven, Belgium. Jan.vandenstock@kuleuven.be.
Geriatric Psychiatry, University Psychiatric Centre KU Leuven, Leuven, Belgium. Jan.vandenstock@kuleuven.be.

Maxime Bertoux (M)

Lille Neurosciences & Cognition Institute, Labex DISTALZ, Univ. Lille, Inserm, CHU Lille, Lille, France.

Janine Diehl-Schmid (J)

School of Medicine, Department of Psychiatry and Psychotherapy, Technical University of Munich, Munich, Germany.

Olivier Piguet (O)

Brain and Mind Centre and School of Psychology, The University of Sydney, Sydney, Australia.

Katherine P Rankin (KP)

Department of Neurology, University of California San Francisco, San Francisco, CA, USA.

Florence Pasquier (F)

Lille Neurosciences & Cognition Institute, Labex DISTALZ, Univ. Lille, Inserm, CHU Lille, Lille, France.

Simon Ducharme (S)

Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Canada.
McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada.

Yolande Pijnenburg (Y)

Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.

Fiona Kumfor (F)

Brain and Mind Centre and School of Psychology, The University of Sydney, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH